Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-003515-22Phase 4Active
Phase 4 trial of tapentadol and oxycodone in chronic pain (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Primary utility outcome. Started Oct 2018; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-003515-22.